Please block out time in your schedule Monday, Nov. 20, to hear Peter Howarth, BSc (Hons), MBBS, DM, FRCP, a professor of allergy and respiratory medicine and honorary consultant physicians with the University of Southampton Faculty of Medicine in Southampton, England.
A special guest speaker on behalf of the Office of the Chair for the UA Department of Medicine and the Division of Genetics, Genomics and Precision Medicine, Prof. Howarth will speak on “Epithelial Injury in Severe Asthma.” The lecture will be from noon-1 p.m. in Room 5403 of the UA College of Medicine - Tucson, 1501 N. Campbell Ave., Tucson, AZ 85724.
Click here [PDF] 
or on the image at left to download, post and share the flyer for this lecture.
Video and audio of the event will be livestreamed and archived for future viewing at this link: http://streaming.biocom.arizona.edu/home/?d=2017/11/20
A light lunch will be served in the style of Grand Rounds.
Prof. Howarth’s clinical and research focus is on asthma, particularly severe asthma, and allergy. He is head of the Clinical Studies Forum in the Clinical and Experimental Science (CES) Research division within the University of Southampton Faculty of Medicine.
He coordinates clinical and translational human based research as well as clinical trials, and serves as lead for “Airways disease” within the CES research division and area lead for “Airways disease” within the NIH-funded Respiratory Bioscience Research Unit in Southampton.
Prof. Howarth has funding from the UK's Medical Research Council (MRC), National Institute of Health Research, Engineering and Physical Sciences Research Council (EPSRC) and Asthma UK as well as industrial funding for his research that addresses the understanding and treatment of severe asthma.
Much of this work makes use of direct airway sampling at bronchoscopy to obtain samples for the evaluation of the airway microbiome, airway inflammatory status, airway remodelling and to obtain samples for ex vivo cell culture studies. Such studies focus, in collaboration, on bronchial epithelial cells, airway mucosal fibroblasts and alveolar macrophages.
These approaches have been used both to compare findings in severe asthma to that in healthy controls and mild asthma as well as to evaluate the impact of standard and novel therapeutic approaches to disease management. On-going work also includes biomarker evaluation and evaluation of novel approaches to lung imaging in airways disease.
For any questions, please contact Claudia Duran, Office of the Chair, (520) 626-6349, crduran@deptofmed.arizona.edu or Cindy Thompson, Division of Genetics, Genomics & Precision Medicine, (520) 626-8624 or crthompson@deptofmed.arizona.edu